Joseph P. Dougherty Elected to Board of Directors of AnorMED! Shareholders of AnorMED Inc. (TSX:AOM, AMEX:AOM) today voted overwhelmingly to elect a new, independent and experienced Board of Directors to work for the benefit of all shareholders. AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has a product in Phase III development, a product in Phase II development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases including HIV. Additional information on AnorMED Inc. is available on the Company’s website www.anormed.com. At a Special Meeting of Shareholders, approximately 74% of the shares voted in support of the eight directors nominated by Baker Bros. Advisors, LLC, on behalf of the funds it manages that are collectively AnorMED’s largest shareholder. The directors nominated by management and the previous Board received approximately 26% of the votes cast. The following individuals were elected as Directors of AnorMED: * Joseph P. Dougherty, Ph.D. Managing Director of Seaview Securities LLC * Felix J. Baker, Ph.D. Managing Member of Baker Bros. Advisors, LLC * Henry Fuchs, M.D., Ph.D., Executive Vice President and Chief Medical Officer, Onyx Pharmaceuticals * And some other guys Immediately following the Special Meeting, the Board of Directors named Mr. Galbraith as Chair and appointed Dr. Michael Abrams, AnorMED’s President and Chief Executive Officer and Dr. William Hunter, Chief Executive Officer of Angiotech as additional Directors. "This new Board of Directors is committed to maximizing long-term value for all AnorMED shareholders. It has already begun its work to effect positive change and to determine a new strategic direction for the Company,” Galbraith said. “We will ensure that AnorMED has the best corporate strategy for growth and that the Company follows the highest standards of independent and active corporate governance.” The Wine Importer salutes the new member of the Board of Directors. We are confident that AnorMED is taking a bold step forward! |
return to: Joe Dressner The Wine Importer |
"...dit/1846/?/ Content-Length: 0 Connection: close Content-Type: text/html; charset=ISO-8859-1 ..." |